Načítá se...
n-Butyl Cyanoacrylate Embolization of Cerebral Arteriovenous Malformations: Results of a Prospective, Randomized, Multi-center Trial
BACKGROUND AND PURPOSE: Liquid n-butyl cyanoacrylate (n-BCA) use for the treatment of arteriovenous malformations (AVM) in the brain has become part of medical practice. However, no study has led to the Food and Drug Administration’s approval of n-BCA for intravascular use. The purpose of this study...
Uloženo v:
| Vydáno v: | AJNR Am J Neuroradiol |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Neuroradiology
2002
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7974739/ https://ncbi.nlm.nih.gov/pubmed/12006271 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|